BNP and NT-proBNP are blood tests that help show whether the heart is under strain, especially when heart failure is suspected. They are closely related, but they are not the same test. BNP is the active hormone that helps the body release sodium and water, relax blood vessels, and reduce pressure on the heart. NT-proBNP is an inactive fragment released at the same time, but it stays in the blood longer and is usually present at higher numbers.
Both tests are most useful when a person has shortness of breath, swelling, fatigue, rapid weight gain, or other symptoms that could come from heart failure. A low result can make heart failure much less likely. A high result supports the possibility of heart failure, but it does not prove it by itself. Age, kidney function, body weight, atrial fibrillation, lung disease, sepsis, and certain heart medicines can all change the result.
- BNP and NT-proBNP both reflect heart wall stretch, most often from increased pressure or fluid overload.
- BNP results are usually reported in pg/mL, and values below 100 pg/mL often help rule out acute heart failure.
- NT-proBNP is usually higher numerically; values below 300 pg/mL often help rule out acute heart failure.
- NT-proBNP tends to be more affected by age and kidney function because it stays in circulation longer.
- BNP can be harder to interpret after starting sacubitril/valsartan, while NT-proBNP is usually preferred for tracking response on that medication.
- A high BNP or NT-proBNP needs clinical follow-up, especially with new shortness of breath, chest pain, fainting, blue lips, or severe swelling.
Table of Contents
- BNP and NT-proBNP in Plain Language
- How the Two Markers Are Made
- Main Differences Between BNP and NT-proBNP
- When Each Test Is Used
- Reference Ranges and Cutoffs
- Why Results Can Be High or Low
- How to Read Results With Other Tests
- Next Steps After an Abnormal Result
BNP and NT-proBNP in Plain Language
BNP and NT-proBNP are natriuretic peptides. “Natriuretic” means they help the body get rid of sodium, and water follows sodium. The heart releases these peptides when its chambers are stretched, usually because pressure or volume inside the heart is higher than normal.
The main reason doctors order BNP or NT-proBNP is to help evaluate possible heart failure. Heart failure does not mean the heart has stopped. It means the heart is not filling, pumping, or relaxing well enough to meet the body’s needs without higher pressure. That pressure can back up into the lungs, legs, belly, or veins and cause symptoms such as shortness of breath, swelling, fatigue, and sudden weight gain.
BNP and NT-proBNP are especially helpful because symptoms of heart failure overlap with many other conditions. Shortness of breath can also come from asthma, COPD, pneumonia, anemia, obesity, anxiety, pulmonary embolism, kidney disease, or a heart rhythm problem. A natriuretic peptide test gives an objective clue about whether the heart is likely involved.
A low result is often more helpful than a mildly high result. Low BNP or NT-proBNP makes heart failure unlikely in many settings. A high result means the heart may be under stress, but the cause still has to be found. The test cannot show the heart’s pumping strength, valve function, rhythm, or fluid status by itself.
BNP and NT-proBNP are related to other cardiac markers, but they answer a different question. Troponin is mainly a marker of heart muscle injury, while BNP and NT-proBNP are markers of heart strain and pressure. That is why a person with chest pain may need troponin and BNP interpreted together, especially when symptoms could involve both heart injury and heart failure.
How the Two Markers Are Made
BNP and NT-proBNP come from the same starting molecule. When heart muscle cells feel stretch, they produce a larger precursor called proBNP. Enzymes then split proBNP into two main pieces:
- BNP, the active hormone
- NT-proBNP, the inactive N-terminal fragment
They are released into the blood at roughly the same time. The difference is what happens afterward. BNP acts on blood vessels, kidneys, and hormone systems to reduce strain on the heart. NT-proBNP does not have the same direct hormone action, but it is useful because it reflects the same release signal from the heart.
BNP is the active hormone
BNP helps the body respond to fluid and pressure overload. It supports sodium loss through the kidneys, increases urine output, relaxes blood vessels, and reduces some of the body’s fluid-retaining hormone signals. In heart failure, the body often activates systems that hold onto salt and water. BNP is one of the body’s counter-responses.
BNP has a shorter half-life than NT-proBNP. In plain terms, it clears from the blood faster. This can make BNP somewhat more reflective of recent changes, though it also means levels may shift more quickly.
NT-proBNP is the inactive companion marker
NT-proBNP is not biologically active in the same way, but it lasts longer in the bloodstream. Because it clears more slowly, the number is usually higher than the BNP number from the same person. A BNP of 80 pg/mL and an NT-proBNP of 250 pg/mL are not equivalent measurements, and they should not be compared as if they use the same scale.
NT-proBNP is also strongly influenced by kidney function because the kidneys help clear it. This does not make the test unreliable. It means interpretation must include kidney function, age, and the clinical situation. For example, an older adult with chronic kidney disease may have a higher baseline NT-proBNP than a younger adult with normal kidney function.
Main Differences Between BNP and NT-proBNP
BNP and NT-proBNP are used for similar reasons, but their numbers, clearance, medication effects, and cutoffs differ. A common mistake is to treat them as interchangeable. They are not.
| Feature | BNP | NT-proBNP |
|---|---|---|
| Full name | B-type natriuretic peptide | N-terminal pro-B-type natriuretic peptide |
| Biologic role | Active hormone | Inactive fragment |
| Source | Released when proBNP is split | Released when proBNP is split |
| Typical blood level | Lower number | Higher number |
| Approximate half-life | Shorter, often about 20 minutes | Longer, often about 1–2 hours |
| Medication issue | Can rise after sacubitril/valsartan | Usually preferred for tracking response on sacubitril/valsartan |
| Kidney function effect | Affected by kidney function | Often more affected by kidney function |
| Best use | Diagnosis and risk assessment when interpreted with symptoms | Diagnosis, risk assessment, and monitoring trends in many heart failure settings |
The numerical difference matters. A BNP result of 150 pg/mL and an NT-proBNP result of 150 pg/mL do not mean the same thing. Laboratories also use different assay methods, so the exact reference interval may vary. The lab’s own range and the doctor’s clinical judgment matter more than a single universal number.
Medication is another important difference. Sacubitril/valsartan, also called an ARNI, blocks neprilysin. Neprilysin helps break down BNP. After this medication is started, BNP may rise or stay higher even when the person is improving. NT-proBNP is not broken down by neprilysin in the same way, so it is often more useful for following treatment response in people taking this medication.
BNP and NT-proBNP are also different from older cardiac enzymes such as CK-MB and myoglobin. Those older tests are more related to muscle injury patterns, while BNP and NT-proBNP are more related to pressure, volume, and heart failure physiology. When the question is heart attack versus heart failure, clinicians may compare natriuretic peptide results with troponin, ECG findings, symptoms, and imaging rather than using one test alone. A broader cardiac biomarker panel may include several markers, but each marker answers a different clinical question.
When Each Test Is Used
BNP and NT-proBNP are used in emergency care, outpatient evaluation, hospital monitoring, and risk assessment. The same blood test can have different meaning depending on the situation.
Sudden shortness of breath
In emergency settings, BNP or NT-proBNP can help separate heart-related shortness of breath from non-heart causes. This is one of their strongest uses. A very low result makes acute heart failure less likely. A high result raises suspicion, especially when the person also has lung crackles, leg swelling, low oxygen, enlarged neck veins, or a chest X-ray showing fluid.
The test does not replace urgent clinical evaluation. A person with severe shortness of breath may need oxygen, ECG, chest imaging, troponin testing, kidney tests, and sometimes urgent treatment before all results are back.
Possible chronic heart failure
In outpatient care, BNP or NT-proBNP may be ordered when symptoms develop gradually. These symptoms may include breathlessness when walking, needing extra pillows at night, waking up gasping, ankle swelling, reduced exercise tolerance, or unexplained fatigue.
A low outpatient BNP or NT-proBNP makes chronic heart failure less likely, though it does not rule out every heart problem. Some people with obesity or heart failure with preserved ejection fraction can have lower-than-expected natriuretic peptide levels. If symptoms are convincing, further evaluation may still be needed.
For a deeper look at interpretation patterns, BNP and NT-proBNP together can be useful when symptoms, fluid status, kidney function, and medication changes all need to be considered.
Known heart failure
In someone already diagnosed with heart failure, BNP or NT-proBNP may help assess severity, risk, and treatment response. Falling levels after treatment often suggest less cardiac strain, especially when symptoms and exam findings are also improving. Rising levels may suggest worsening congestion, poor medication response, kidney stress, a new rhythm problem, infection, or another trigger.
Trends are often more useful than isolated numbers. A person whose NT-proBNP falls from 6,000 to 1,800 pg/mL after treatment is usually showing a meaningful improvement, even though 1,800 pg/mL may still be high. A person whose value rises from 300 to 1,200 pg/mL may need closer evaluation, even if the absolute number is lower than in many hospitalized patients.
Reference Ranges and Cutoffs
BNP and NT-proBNP cutoffs depend on whether the person is being evaluated for acute symptoms or chronic symptoms. They also depend on age, kidney function, body weight, and the lab method used.
The ranges below are common clinical guideposts, not personal diagnostic rules.
| Setting | BNP | NT-proBNP | General meaning |
|---|---|---|---|
| Acute shortness of breath | Less than 100 pg/mL | Less than 300 pg/mL | Heart failure is less likely |
| Outpatient or non-acute symptoms | Less than 35 pg/mL | Less than 125 pg/mL | Chronic heart failure is less likely |
| Possible acute heart failure, age under 50 | Often interpreted with the 100 pg/mL rule-out threshold | Above about 450 pg/mL may support heart failure | Interpret with symptoms and exam |
| Possible acute heart failure, age 50–75 | Often interpreted with the 100 pg/mL rule-out threshold | Above about 900 pg/mL may support heart failure | Age raises expected NT-proBNP values |
| Possible acute heart failure, age over 75 | Often interpreted with the 100 pg/mL rule-out threshold | Above about 1,800 pg/mL may support heart failure | False positives are more common |
The “rule-out” values are designed to make heart failure less likely when the result is low. They are not designed to prove heart failure when the result is mildly above the cutoff. This difference matters. BNP of 120 pg/mL in a stable older adult with kidney disease and no fluid overload has a different meaning than BNP of 900 pg/mL in a person with sudden breathlessness and swollen legs.
NT-proBNP often uses age-adjusted rule-in thresholds in acute care because levels rise with age. BNP also rises with age, but age-adjusted NT-proBNP thresholds are commonly emphasized because the marker has a longer half-life and higher baseline values in older adults.
Laboratory reports may label results as normal, borderline, or high, but heart failure diagnosis requires more than a lab flag. Echocardiography is often needed to evaluate ejection fraction, valve disease, chamber size, wall thickness, and filling pressures. Kidney function, electrolytes, blood count, thyroid tests, liver tests, ECG, and chest imaging may also be part of the workup.
Why Results Can Be High or Low
High BNP or NT-proBNP usually means the heart is experiencing stretch, pressure, or volume overload. Heart failure is the most common reason clinicians think about first, but it is not the only reason.
Common causes of high BNP or NT-proBNP include:
- Heart failure with reduced ejection fraction
- Heart failure with preserved ejection fraction
- Atrial fibrillation or other rapid heart rhythms
- Pulmonary hypertension
- Right-sided heart strain from lung disease or pulmonary embolism
- Acute coronary syndrome or recent heart attack
- Significant valve disease, such as aortic stenosis or mitral regurgitation
- Kidney disease or acute kidney injury
- Sepsis, severe infection, or critical illness
- Severe anemia
- Older age
- Uncontrolled high blood pressure
Kidney function deserves special attention. When kidney filtration falls, BNP and especially NT-proBNP can accumulate. A high NT-proBNP in chronic kidney disease may still signal heart risk, but the threshold for concern may differ. That is why natriuretic peptide results are often interpreted alongside creatinine and eGFR. A change in kidney function can make a heart marker look worse even when the main problem is not new heart failure.
Obesity can have the opposite effect. People with higher body mass index often have lower BNP and NT-proBNP levels than expected for the same amount of heart stress. This can make heart failure harder to recognize, especially heart failure with preserved ejection fraction. A low or borderline result should be interpreted carefully when symptoms and exam findings strongly suggest congestion.
Sex and age also influence results. On average, natriuretic peptide levels rise with age and tend to be somewhat higher in women than in men. These differences do not diagnose disease by themselves, but they help explain why a single cutoff cannot fit every person equally well.
Medications can change trends. Diuretics, blood pressure medicines, mineralocorticoid receptor antagonists, SGLT2 inhibitors, and other heart failure therapies may lower BNP or NT-proBNP as congestion improves. Sacubitril/valsartan is the special case because BNP may rise due to neprilysin inhibition, while NT-proBNP often falls when the heart is responding well.
Low results are usually reassuring, but they are not perfect. BNP and NT-proBNP can be low in early disease, obesity, treated stable heart failure, or some forms of preserved-ejection-fraction heart failure. The result should always be matched to the person in front of the clinician, not interpreted as a stand-alone verdict.
How to Read Results With Other Tests
BNP and NT-proBNP become much more useful when paired with symptoms, physical exam findings, and related tests. A number alone can mislead.
Symptoms and exam findings
Symptoms that fit heart failure include shortness of breath with activity, trouble lying flat, waking up breathless, swelling in the ankles or belly, rapid weight gain from fluid, fatigue, and reduced exercise tolerance. Exam findings may include crackles in the lungs, swollen neck veins, leg edema, an enlarged liver, or a new heart murmur.
When symptoms and BNP or NT-proBNP point in the same direction, the result is stronger. For example, NT-proBNP of 4,500 pg/mL in a person with sudden breathlessness, low oxygen, swollen legs, and fluid on chest X-ray strongly supports heart failure. NT-proBNP of 700 pg/mL in an older adult with kidney disease and pneumonia may be harder to interpret.
Echocardiogram
An echocardiogram is often the next major test after a clearly abnormal BNP or NT-proBNP, especially if heart failure has not been diagnosed before. It can show whether the left ventricle pumps weakly, whether the heart is stiff, whether valves are narrowed or leaking, whether the right side of the heart is strained, and whether pressures appear elevated.
BNP and NT-proBNP do not tell whether heart failure is reduced ejection fraction or preserved ejection fraction. Both forms can raise natriuretic peptides. The distinction matters because treatment choices may differ.
Troponin, ECG, and chest imaging
Troponin helps detect heart muscle injury. BNP and NT-proBNP help detect heart strain. Both can be high in serious illness, and both can rise after a heart attack. In chest pain, shortness of breath, or suspected acute coronary syndrome, clinicians often check troponin, ECG, and natriuretic peptides together. A patient with a high high-sensitivity troponin and high NT-proBNP needs careful evaluation for myocardial injury, heart failure, rhythm problems, kidney disease, or combined illness.
Chest X-ray or lung ultrasound can show fluid in or around the lungs. These findings can support heart failure, but imaging can also show pneumonia, collapsed lung, pleural effusion, or other causes of breathing symptoms.
Kidney tests, electrolytes, and blood count
A basic metabolic panel or comprehensive metabolic panel helps check kidney function, sodium, potassium, bicarbonate, and other chemistry markers. These results matter because kidney disease can raise NT-proBNP and because heart failure treatment often changes kidney function and electrolytes.
A complete blood count can reveal anemia or infection. Severe anemia can strain the heart and raise natriuretic peptides. Infection and sepsis can also increase BNP or NT-proBNP even when the main problem is not chronic heart failure.
Next Steps After an Abnormal Result
An abnormal BNP or NT-proBNP should be acted on according to symptoms, severity, and previous medical history. The same number can mean different things in different situations.
Urgent medical care is needed when a high or rising BNP or NT-proBNP occurs with severe shortness of breath, chest pain, fainting, confusion, blue lips, coughing pink frothy sputum, oxygen levels below the person’s usual range, or rapidly worsening swelling. These symptoms may signal acute heart failure, heart attack, pulmonary embolism, dangerous rhythm disturbance, or another emergency.
For less urgent symptoms, follow-up often includes:
- Reviewing the full history, including heart disease, high blood pressure, kidney disease, diabetes, atrial fibrillation, lung disease, sleep apnea, and medications.
- Repeating or confirming the test if the result does not fit the clinical picture.
- Checking kidney function, electrolytes, blood count, thyroid function, and sometimes liver tests.
- Ordering an echocardiogram when heart failure, valve disease, or structural heart disease is possible.
- Comparing the result with prior BNP or NT-proBNP levels, if available.
- Adjusting treatment only when the result matches the overall clinical assessment.
People with known heart failure should avoid reacting to one lab value without considering symptoms and trends. A single mildly higher number after a salty meal, missed diuretic dose, infection, or kidney function change may not mean the same thing as a steady rise over several weeks with worsening breathlessness and weight gain.
People without a heart failure diagnosis should not ignore a clearly high result. Even when the final cause is not heart failure, elevated BNP or NT-proBNP often signals higher cardiovascular risk. It may reveal atrial fibrillation, valve disease, pulmonary hypertension, kidney disease, or previously unrecognized structural heart disease.
For a focused look at each individual test, separate guides to the BNP blood test and the NT-proBNP blood test can help clarify why a clinician may order one marker instead of the other.
The safest way to think about BNP and NT-proBNP is simple: they are heart strain markers, not complete diagnoses. Low values can be reassuring. High values deserve context. Trends can be powerful. The best interpretation comes from combining the lab result with symptoms, exam findings, kidney function, ECG, imaging, and the person’s known heart history.
References
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure 2022 (Guideline)
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2021 (Guideline)
- 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2023 (Guideline)
- Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society 2023 (Scientific Statement)
- Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESC 2023 (Consensus Statement)
- The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes 2024 (Review)
Disclaimer
BNP and NT-proBNP results should be interpreted by a qualified healthcare professional who can review symptoms, exam findings, kidney function, medications, and prior test results. Seek urgent care for severe shortness of breath, chest pain, fainting, confusion, blue lips, or rapidly worsening swelling. This information is educational and does not replace medical diagnosis or treatment.
